Cleared Traditional

K914847 - CD8 MONOCLONAL ANTIBODIES

K914847 is an FDA 510(k) clearance for CD8 MONOCLONAL ANTIBODIES, manufactured by Gen Trak, Inc.. The device is a Class 2 Hematology device with product code LIZ cleared through the Traditional 510(k) pathway after a 235-day FDA review.

K914847 · Gen Trak, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1992
Decision
235d
Days
Class 2
Risk

K914847 is an FDA 510(k) clearance for the CD8 MONOCLONAL ANTIBODIES. Classified as Assay, T Lymphocyte Surface Marker (product code LIZ), Class II - Special Controls.

Submitted by Gen Trak, Inc. (Plymouth Meeting, US). The FDA issued a Cleared decision on June 19, 1992 after a review of 235 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Gen Trak, Inc. devices

FDA 510(k) Submission Details - K914847

510(k) Number K914847 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 1991
Decision Date June 19, 1992
Days to Decision 235 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
122d slower than avg
Panel avg: 113d · This submission: 235d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIZ Device Classification - Class 2, Special Controls

Product Code LIZ Assay, T Lymphocyte Surface Marker
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - LIZ Assay, T Lymphocyte Surface Marker

Devices cleared under the same product code (LIZ) and FDA review panel - the closest regulatory comparables to K914847.
TECHNICON H.1 SYSTEM, T LYMPHOCYTES METHOD
K860830 · Technicon Instruments Corp. · Sep 1986
TBM-REAGENT FOR T,B CELL & MONOCYTES
K843062 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1985
ANTI-LEU-4 FITC LYSIN C BUFFER
K842218 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1984
QUANTIGEN T & B CELL ASSAY
K831053 · Bio-Rad · Aug 1983
ORTHO SPECTRUM III & ORTHO-MUNE OK
K820643 · Ortho Diagnostic Systems, Inc. · Jul 1982